EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Increasing patient participation in oncology clinical trials

Jie Chen, Ying Lu, Shivaani Kummar iD

Cancer Medicine · 2023-02 · 12 (3) · 2219-2226

DOI: 10.1002/cam4.5150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 31.08.2022. Verfasst von Jie Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biometrics, Overland Pharmaceuticals, Dover, Delaware, USA. Hauptthemen laut MEDLINE: Neoplasms, Physicians. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non‐oncology trials.

Methods

In this paper we further elaborate on the challenges for patient participation in oncology trials from physician, patient, healthcare system, and some trial‐related perspectives.

Results

We present strategies such as use of digital healthcare technologies, real‐world data and real‐world evidence, decentralized clinical trials, pragmatic trial designs, and supportive services to increase patient participation.

Conclusions

Multifaceted measures are necessary to increase patient participation, especially for those who are under‐represented in cancer trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPhysiciansHumansPatient SelectionPatient ParticipationMedical Oncology

Stichwörter der Autor:innen

cancer trialsclinical trialspatient accrualpragmatic clinical trials

Autor:innen und Institutionen

  • Department of Biometrics, Overland Pharmaceuticals, Dover, Delaware, USA.
  • Department of Biomedical Data Science and Stanford Cancer Institute, Stanford University, Palo Alto, California, USA.
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

ORCID-Profile: Shivaani Kummar

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chen, J., Lu, Y., & Kummar, S. (2023). Increasing patient participation in oncology clinical trials. Cancer Medicine, 12(3), 2219-2226. https://doi.org/10.1002/cam4.5150

Vancouver

Chen J, Lu Y, Kummar S. Increasing patient participation in oncology clinical trials. Cancer Medicine. 2023;12(3):2219-2226. doi:10.1002/cam4.5150

BibTeX
@article{Chen2023,
  author = {Chen, Jie and Lu, Ying and Kummar, Shivaani},
  title = {Increasing patient participation in oncology clinical trials},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {2219--2226},
  doi = {10.1002/cam4.5150}
}
Kostenlos starten →